(Q51599426)

English

Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in type 2 (non-insulin-dependent) diabetic patients.

scientific article published in August 1993

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/8405741

Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in type 2 (non-insulin-dependent) diabetic patients. (English)

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/8405741

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Jens Juul Holst

4

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/8405741

author name string

M A Nauck

1

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/8405741

N Kleine

2

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/8405741

C Orskov

3

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/8405741

B Willms

5

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/8405741

W Creutzfeldt

6

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/8405741

publication date

1 August 1993

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/8405741

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/8405741

36

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/8405741

741-744

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/8405741

8

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/8405741

https://scigraph.springernature.com/pub.10.1007/bf00401145

0 references

Glucagon-like peptide-1, a new hormone of the entero-insular axis

1 reference

https://pubmed.ncbi.nlm.nih.gov/8405741

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Insulinotropic action of glucagonlike peptide-I-(7-37) in diabetic and nondiabetic subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/8405741

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glucagon-like peptide-1 cells in the gastrointestinal tract and pancreas of rat, pig and man

1 reference

https://pubmed.ncbi.nlm.nih.gov/8405741

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations

1 reference

https://pubmed.ncbi.nlm.nih.gov/8405741

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Abnormal patterns of insulin secretion in non-insulin-dependent diabetes mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/8405741

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glucagon-like peptide-1 7-36: a physiological incretin in man.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8405741

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glucagonostatic and insulinotropic action of glucagonlike peptide I-(7-36)-amide

1 reference

https://pubmed.ncbi.nlm.nih.gov/8405741

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/8405741

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radio-immunoassays for glucagon-like peptides 1 and 2 (GLP-1 and GLP-2).

1 reference

https://pubmed.ncbi.nlm.nih.gov/8405741

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/8405741

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evidence that enteroglucagon (II) is identical with the C-terminal sequence (residues 33-69) of glicentin

1 reference

https://pubmed.ncbi.nlm.nih.gov/8405741

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of truncated glucagon-like peptide-1 [proglucagon-(78-107) amide] on endocrine secretion from pig pancreas, antrum, and nonantral stomach.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8405741

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00401145

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/8405741

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/8405741

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51599426&oldid=1388626228"